Search results
Kyverna Therapeutics Inc. (KYTX) Stock Showcases
NewsHeater· 5 hours agoThe volatility ratio for the week is 9.90%, and the volatility levels for the past 30 days are at 7.63% for KYTX. The simple moving average for the past 20 days is -18.29% for KYTX’s
Wedbush Reaffirms Outperform Rating for MGP Ingredients (NASDAQ:MGPI)
ETF DAILY NEWS· 7 hours agoWedbush currently has a $120.00 price target on the stock. Roth Mkm lowered their price target on MGP Ingredients from $100.00 to $95.00 and set a buy rating for the company ...
Sigma Planning Corp Has $443,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)
ETF DAILY NEWS· 6 days agoSigma Planning Corp cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 51.7% during the fourth quarter, according to its most recent disclosure with the ...
LendingTree (NASDAQ:TREE) Hits New 52-Week High on Analyst Upgrade
ETF DAILY NEWS· 5 hours agoShares of LendingTree, Inc. (NASDAQ:TREE – Get Free Report) hit a new 52-week high during trading on Tuesday after Keefe, Bruyette & Woods raised their price target on the stock< ...
Atrion (NASDAQ:ATRI) Downgraded by StockNews.com to “Sell”
ETF DAILY NEWS· 6 hours agoAtrion has a 12-month low of $274.98 and a 12-month high of $615.30. Atrion (NASDAQ:ATRI – Get Free Report) last announced its quarterly earnings results on Thursday, February 29th. Atrion had ...
SM Energy (NYSE:SM) Shares Acquired by International Assets Investment Management LLC
ETF DAILY NEWS· 6 hours agoReport) by 3,772.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,394 shares of the energy company ...
3 Top Penny Stocks to Buy for Explosive Returns: April Edition
InvestorPlace· 1 day agoFirst, when it comes to penny stocks, you have to understand the high risk involved. Because it may...
Krystal Biotech, Inc. (NASDAQ:KRYS) Given Average Rating of “Buy” by Analysts
ETF DAILY NEWS· 6 days agoSeveral brokerages have recently weighed in on KRYS. Guggenheim upped their price target on shares of Krystal Biotech from $130.00 to $175.00 and gave the stock< ...
Ginkgo Bioworks: Buy, Sell, or Hold?
Motley Fool via Yahoo Finance· 2 days agoIn a world where biotechnology is always becoming more sophisticated, manufacturing-oriented biotech businesses like Ginkgo Bioworks (NYSE: DNA) are...
What Recent Market Trends Mean for SpringWorks Therapeutics Inc’s
NewsHeater· 9 hours agoIs It Worth Investing in SpringWorks Therapeutics Inc (NASDAQ: SWTX) Right Now? The public float for SWTX is 62.80M and currently, short sellers...
